Clinical trial NCT02774265 - References

Pulmonary Embolism — A Different Approach to Preventing Thrombosis

Citation(s)

•   Anderson DR, Dunbar MJ, Bohm ER, Belzile E, Kahn SR, Zukor D, Fisher W, Gofton W, Gross P, Pelet S, Crowther M, MacDonald S, Kim P, Pleasance S, Davis N, Andreou P, Wells P, Kovacs M, Rodger MA, Ramsay T, Carrier M, Vendittoli PA
  Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med. 2013 Jun 4;158(11):800-6. doi: 10.7326/0003-4819-158-11-201306040-00004.
•   Bozic KJ, Vail TP, Pekow PS, Maselli JH, Lindenauer PK, Auerbach AD
  Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty. 2010 Oct;25(7):1053-60. doi: 10.1016/j.arth.2009.06.021. Epub 2009 Aug 12.
•   Brakenridge SC, Henley SS, Kashner TM, Golden RM, Paik DH, Phelan HA, Cohen MJ, Sperry JL, Moore EE, Minei JP, Maier RV, Cuschieri J; Inflammation and the Host Response to Injury Investigators
  Comparing clinical predictors of deep venous thrombosis versus pulmonary embolus after severe injury: a new paradigm for posttraumatic venous thromboembolism? J Trauma Acute Care Surg. 2013 May;74(5):1231-7; discussion 1237-8. doi: 10.1097/TA.0b013e31828cc9a0.
•   Brookenthal KR, Freedman KB, Lotke PA, Fitzgerald RH, Lonner JH
  A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty. 2001 Apr;16(3):293-300.
•   Burnett RS, Clohisy JC, Wright RW, McDonald DJ, Shively RA, Givens SA, Barrack RL
  Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty. 2007 Apr;22(3):317-24.
•   Cohen AT, Imfeld S, Markham J, Granziera S
  The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders. Thromb Res. 2015 Feb;135(2):217-25. doi: 10.1016/j.thromres.2014.11.036. Epub 2014 Dec 13. Review.
•   Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients
  Antiplatelet Trialists' Collaboration. BMJ. 1994 Jan 22;308(6923):235-46.
•   Cossetto DJ, Goudar A, Parkinson K
  Safety of peri-operative low-dose aspirin as a part of multimodal venous thromboembolic prophylaxis for total knee and hip arthroplasty. J Orthop Surg (Hong Kong). 2012 Dec;20(3):341-3.
•   Goel DP, Buckley R, deVries G, Abelseth G, Ni A, Gray R
  Prophylaxis of deep-vein thrombosis in fractures below the knee: a prospective randomised controlled trial. J Bone Joint Surg Br. 2009 Mar;91(3):388-94. doi: 10.1302/0301-620X.91B3.20820.
•   Greenfield LJ, Proctor MC, Rodriguez JL, Luchette FA, Cipolle MD, Cho J
  Posttrauma thromboembolism prophylaxis. J Trauma. 1997 Jan;42(1):100-3.
•   Gritsiouk Y, Hegsted DA, Schlesinger P, Gardiner SK, Gubler KD
  A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients. Am J Surg. 2014 May;207(5):648-51; discussion 651-2. doi: 10.1016/j.amjsurg.2013.12.010. Epub 2014 Jan 30.
•   Hak DJ
  Prevention of venous thromboembolism in trauma and long bone fractures. Curr Opin Pulm Med. 2001 Sep;7(5):338-43. Review.
•   Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, DeSanctis RW
  Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med. 1977 Dec 8;297(23):1246-9.
•   Hill J, Treasure T; Guideline Development Group
  Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline. Heart. 2010 Jun;96(11):879-82. doi: 10.1136/hrt.2010.198275.
•   Jørgensen PS, Warming T, Hansen K, Paltved C, Vibeke Berg H, Jensen R, Kirchhoff-Jensen R, Kjaer L, Kerbouche N, Leth-Espensen P, Narvestad E, Rasmussen SW, Sloth C, Tørholm C, Wille-Jørgensen P
  Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study. Thromb Res. 2002 Mar 15;105(6):477-80.
•   Lassen MR, Borris LC, Nakov RL
  Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med. 2002 Sep 5;347(10):726-30.
•   Lieberman JR, Pensak MJ
  Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2013 Oct 2;95(19):1801-11. doi: 10.2106/JBJS.L.01328. Review.
•   Lotke PA, Palevsky H, Keenan AM, Meranze S, Steinberg ME, Ecker ML, Kelley MA
  Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop Relat Res. 1996 Mar;(324):251-8.
•   McKenna R, Galante J, Bachmann F, Wallace DL, Kaushal PS, Meredith P
  Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J. 1980 Feb 23;280(6213):514-7.
•   Mont MA, Jacobs JJ
  AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg. 2011 Dec;19(12):777-8.
•   Mortazavi SM, Hansen P, Zmistowski B, Kane PW, Restrepo C, Parvizi J
  Hematoma following primary total hip arthroplasty: a grave complication. J Arthroplasty. 2013 Mar;28(3):498-503. doi: 10.1016/j.arth.2012.07.033. Epub 2012 Oct 31.
•   Myers DD Jr, Rectenwald JE, Bedard PW, Kaila N, Shaw GD, Schaub RG, Farris DM, Hawley AE, Wrobleski SK, Henke PK, Wakefield TW
  Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg. 2005 Aug;42(2):329-36.
•   Myers DD Jr, Wrobleski SK, Longo C, Bedard PW, Kaila N, Shaw GD, Londy FJ, Rohrer SE, Fex BA, Zajkowski PJ, Meier TR, Hawley AE, Farris DM, Ballard NE, Henke PK, Schaub RG, Wakefield TW
  Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation. Thromb Haemost. 2007 Mar;97(3):400-7.
•   Novicoff WM, Brown TE, Cui Q, Mihalko WM, Slone HS, Saleh KJ
  Mandated venous thromboembolism prophylaxis: possible adverse outcomes. J Arthroplasty. 2008 Sep;23(6 Suppl 1):15-9. doi: 10.1016/j.arth.2008.04.014. Epub 2008 Jun 13.
•   Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
  Lancet. 2000 Apr 15;355(9212):1295-302.
•   Raphael IJ, Tischler EH, Huang R, Rothman RH, Hozack WJ, Parvizi J
  Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty? Clin Orthop Relat Res. 2014 Feb;472(2):482-8. doi: 10.1007/s11999-013-3135-z.
•   Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA
  Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma. 2002 Jul;53(1):142-64. Review.
•   Sagi HC, Dziadosz D, Mir H, Virani N, Olson C
  Obesity, leukocytosis, embolization, and injury severity increase the risk for deep postoperative wound infection after pelvic and acetabular surgery. J Orthop Trauma. 2013 Jan;27(1):6-10. doi: 10.1097/BOT.0b013e31825cf382.
•   Schousboe JT, Brown GA
  Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty. J Bone Joint Surg Am. 2013 Jul 17;95(14):1256-64. doi: 10.2106/JBJS.L.00400.
•   Schumacher WA, Heran CL
  Effect of thromboxane receptor antagonists on venous thrombosis in rats. J Pharmacol Exp Ther. 1989 Mar;248(3):1109-15.
•   Scolaro JA, Taylor RM, Wigner NA
  Venous thromboembolism in orthopaedic trauma. J Am Acad Orthop Surg. 2015 Jan;23(1):1-6. doi: 10.5435/JAAOS-23-01-1.
•   Selby R, Geerts WH, Kreder HJ, Crowther MA, Kaus L, Sealey F; D-KAF (Dalteparin in Knee-to-Ankle Fracture) Investigators
  A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures. J Orthop Trauma. 2015 May;29(5):224-30. doi: 10.1097/BOT.0000000000000250.
•   Slavik RS, Chan E, Gorman SK, de Lemos J, Chittock D, Simons RK, Wing PC, Ho SG
  Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial. J Trauma. 2007 May;62(5):1075-81; discussion 1081.
•   Slobogean GP, Lefaivre KA, Nicolaou S, O'Brien PJ
  A systematic review of thromboprophylaxis for pelvic and acetabular fractures. J Orthop Trauma. 2009 May-Jun;23(5):379-84. doi: 10.1097/BOT.0b013e3181a5369c. Review.
•   Stannard JP, Lopez-Ben RR, Volgas DA, Anderson ER, Busbee M, Karr DK, McGwin GR Jr, Alonso JE
  Prophylaxis against deep-vein thrombosis following trauma: a prospective, randomized comparison of mechanical and pharmacologic prophylaxis. J Bone Joint Surg Am. 2006 Feb;88(2):261-6.
•   Steele N, Dodenhoff RM, Ward AJ, Morse MH
  Thromboprophylaxis in pelvic and acetabular trauma surgery. The role of early treatment with low-molecular-weight heparin. J Bone Joint Surg Br. 2005 Feb;87(2):209-12.
•   Stewart DW, Freshour JE
  Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence. Ann Pharmacother. 2013 Jan;47(1):63-74. doi: 10.1345/aph.1R331. Epub 2013 Jan 16. Review.
•   Vesterqvist O, Gréen K, Johnsson H
  Thromboxane and prostacyclin formation in patients with deep vein thrombosis. Thromb Res. 1987 Feb 15;45(4):393-402.
•   Vulcano E, Gesell M, Esposito A, Ma Y, Memtsoudis SG, Gonzalez Della Valle A
  Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol. Int Orthop. 2012 Oct;36(10):1995-2002. doi: 10.1007/s00264-012-1588-4. Epub 2012 Jun 12.
•   Watson HG, Chee YL
  Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism. Blood Rev. 2008 Mar;22(2):107-16. doi: 10.1016/j.blre.2007.11.001. Epub 2008 Jan 15. Review.

A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Low Molecular Weight Heparin to Acetylsalicylic Acid in Orthopedic Trauma Patients

Details for clinical trial NCT02774265